Rigshospitalet is the largest hospital in Denmark and the most highly specialised hospital in the country. The hospital's main building is a 16-storey functionalist highrise, one of the tallest structures in the central parts of the city.

There are 1,118 beds in Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet.

During the past decade, Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet" #1 collaborator was "University of Copenhagen" with 2 trials as a collaborator, "Curasight" with 1 trials as a collaborator, "Curasight ApS" with 1 trials as a collaborator and "European Foundation for the Study of Diabetes" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet" are "Breast Cancer" (4 trials), "Neuroendocrine Tumors" (2 trials), "Prostate Cancer" (2 trials), "Small Cell Lung Cancer" (2 trials) and "Urinary Bladder Cancer" (2 trials). Many other conditions were trialed in "Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet" in a lesser frequency.

Most popular intervention types in "Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet" are "Device" (10 trials), "Drug" (8 trials), "Other" (5 trials), "Behavioral" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "68Ga-NODAGA-E[c(RGDyK)]2" (2 trials), "68Ga-NOTA-AE105 PET/CT" (2 trials), "FLT-PET" (2 trials), "Inhalation from a salt particle inhaler with or without content" (2 trials) and "Injection of 68Ga-NOTA-AE105" (2 trials). Other intervention names were less common.

The vast majority of trials in "Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet" are 17 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".